Fibclot

Human Fibrinogen (Fibclot) is a clotting factor used to manage bleeding disorders. This intravenous medication supports blood coagulation, crucial for surgical or trauma-related bleeding. Learn more about its uses and effects.

Human Fibrinogen, marketed as Fibclot, is primarily used to control bleeding in individuals with congenital fibrinogen deficiency. It is often administered intravenously to promote clotting during surgical procedures or in cases of trauma. This medication is essential for managing conditions where the body's natural clotting process is impaired, ensuring effective hemostasis.

When administered, Human Fibrinogen works to enhance the blood's ability to clot, which can help stop bleeding more quickly. Common effects may include localized reactions at the injection site, such as redness or swelling. Some individuals might experience mild systemic reactions, but these are generally temporary and subside as the body adjusts to the medication.

Human Fibrinogen should be used with caution in individuals with a history of allergic reactions to blood products. It is important to inform your healthcare provider about any existing medical conditions or medications you are taking. Proper storage and handling are crucial to maintain the efficacy and safety of the product.

Human Fibrinogen may interact with other medications that affect blood clotting, such as anticoagulants or antiplatelet drugs. It is advisable to consult with a healthcare professional before combining it with other treatments. Additionally, alcohol consumption should be moderated, as it can interfere with the medication's effectiveness.